Taylor, Cottrill, Erickson & Associates, Inc. Abbott Laboratories Transaction History

Taylor, Cottrill, Erickson & Associates, Inc.

$359 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$100.78 - $112.29 $185,838 - $207,062	1,844 New	1,844 $201,000
Q4 2022 Jan 31, 2023	BUY	$95.06 - $111.52 $175,290 - $205,642	1,844 New	1,844 $202,000
Q1 2022 May 03, 2022	BUY	$114.02 - $139.04 $11,402 - $13,904	100 Added 5.73%	1,844 $218,000
Q4 2021 Feb 03, 2022	SELL	$115.53 - $141.46 $3.69 Million - $4.52 Million	-31,933 Reduced 94.82%	1,744 $245,000
Q3 2021 Oct 15, 2021	BUY	$116.66 - $129.06 $100,327 - $110,991	860 Added 2.62%	33,677 $3.98 Million
Q2 2021 Jul 20, 2021	SELL	$105.79 - $124.53 $21,158 - $24,906	-200 Reduced 0.61%	32,817 $3.8 Million
Q1 2021 Apr 14, 2021	SELL	$108.84 - $128.23 $22,312 - $26,287	-205 Reduced 0.62%	33,017 $3.96 Million
Q4 2020 Jan 25, 2021	BUY	$105.0 - $114.42 $71,400 - $77,805	680 Added 2.09%	33,222 $3.64 Million
Q3 2020 Oct 09, 2020	SELL	$91.64 - $111.29 $38,947 - $47,298	-425 Reduced 1.29%	32,542 $3.54 Million
Q2 2020 Jul 14, 2020	SELL	$76.57 - $98.0 $1,531 - $1,960	-20 Reduced 0.06%	32,967 $3.01 Million
Q1 2020 Apr 15, 2020	SELL	$62.82 - $91.86 $129,786 - $189,782	-2,066 Reduced 5.89%	32,987 $2.6 Million
Q4 2019 Jan 14, 2020	SELL	$78.51 - $87.4 $30,854 - $34,348	-393 Reduced 1.11%	35,053 $3.05 Million
Q3 2019 Oct 25, 2019	SELL	$81.84 - $88.74 $23,160 - $25,113	-283 Reduced 0.79%	35,446 $2.97 Million
Q2 2019 Jul 26, 2019	SELL	$72.88 - $85.0 $39,355 - $45,900	-540 Reduced 1.49%	35,729 $3.01 Million
Q1 2019 Apr 29, 2019	SELL	$66.22 - $80.06 $26,488 - $32,024	-400 Reduced 1.09%	36,269 $2.9 Million
Q4 2018 Jan 29, 2019	SELL	$65.56 - $74.27 $14,751 - $16,710	-225 Reduced 0.61%	36,669 $2.65 Million
Q3 2018 Oct 24, 2018	SELL	$60.81 - $73.36 $75,404 - $90,966	-1,240 Reduced 3.25%	36,894 $2.71 Million
Q2 2018 Jul 30, 2018	BUY	$57.57 - $63.54 $28,785 - $31,770	500 Added 1.33%	38,134 $2.33 Million
Q1 2018 Apr 23, 2018	SELL	$56.27 - $63.62 $5,627 - $6,362	-100 Reduced 0.27%	37,634 $2.26 Million
Q4 2017 Jan 24, 2018	SELL	$53.68 - $57.47 $9,394 - $10,057	-175 Reduced 0.46%	37,734 $2.15 Million
Q3 2017 Oct 19, 2017	BUY	$48.06 - $53.64 $1.82 Million - $2.03 Million	37,909	37,909 $2.02 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$19.7 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$15.4 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$7.71 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.25 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor, Cottrill, Erickson & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Taylor, Cottrill, Erickson & Associates, Inc. with notifications on news.

Account